Construction of Novel Prognostic Nomogram for Mucinous and Signet Ring Cell Colorectal Cancer Patients with a Survival Longer Than 5 Years

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.21654
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi:10.1016/S0140-6736(19)32319-0
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.21601
   PubMed Web of Science ®Google Scholar
• Siegel RL, Torre LA, Soerjomataram I, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut. 2019;68(12):2179–2185. doi:10.1136/gutjnl-2019-319511
   PubMed Web of Science ®Google Scholar
• Leopoldo S, Lorena B, Cinzia A, et al. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features. Ann Surg Oncol. 2008;15(5):1429–1439. doi:10.1245/s10434-007-9757-1
   PubMed Web of Science ®Google Scholar
• Börger ME, Gosens MJ, Jeuken JW, et al. Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol. 2007;212(3):278–286. doi:10.1002/path.2181
   PubMed Web of Science ®Google Scholar
• Hugen N, van Beek JJ, de Wilt JH, et al. Insight into mucinous colorectal carcinoma: clues from etiology. Ann Surg Oncol. 2014;21(9):2963–2970. doi:10.1245/s10434-014-3706-6
   PubMed Web of Science ®Google Scholar
• Song IH, Hong SM, Yu E, et al. Signet ring cell component predicts aggressive behaviour in colorectal mucinous adenocarcinoma. Pathology. 2019;51(4):384–391. doi:10.1016/j.pathol.2019.03.001
   PubMed Web of Science ®Google Scholar
• Nitsche U, Zimmermann A, Späth C, et al. Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis. Ann Surg. 2013;258(5):775–82;discussion 82–3. doi:10.1097/SLA.0b013e3182a69f7e
   PubMed Web of Science ®Google Scholar
• Luo C, Cen S, Ding G, et al. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun. 2019;39(1):13. doi:10.1186/s40880-019-0361-0
   Web of Science ®Google Scholar
• Hyngstrom JR, Hu CY, Xing Y, et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012;19(9):2814–2821. doi:10.1245/s10434-012-2321-7
   PubMed Web of Science ®Google Scholar
• Kang H, O’Connell JB, Maggard MA, et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. 2005;48(6):1161–1168. doi:10.1007/s10350-004-0932-1
   PubMed Web of Science ®Google Scholar
• Hugen N, Verhoeven RH, Lemmens VE, et al. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor. Int J Cancer. 2015;136(2):333–339. doi:10.1002/ijc.28981
   PubMed Web of Science ®Google Scholar
• Lin JX, Lin JP, Xie JW, et al. Is the AJCC TNM staging system still appropriate for gastric cancer patients survival after 5 years? Eur J Surg Oncol. 2019;45(6):1115–1120. doi:10.1016/j.ejso.2019.01.002
   PubMed Web of Science ®Google Scholar
• Dogrusöz M, Brouwer NJ, de Geus SJR, et al. Prognostic factors five years after enucleation for uveal melanoma. Invest Ophthalmol Vis Sci. 2020;61(3):31. doi:10.1167/iovs.61.3.31
   PubMed Web of Science ®Google Scholar
• Kneuertz PJ, Chang GJ, Hu CY, et al. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg. 2015;150(5):402–409. doi:10.1001/jamasurg.2014.3572
   PubMed Web of Science ®Google Scholar
• Wang MJ, Ping J, Li Y, et al. The prognostic factors and multiple biomarkers in young patients with colorectal cancer. Sci Rep. 2015;5:10645. doi:10.1038/srep10645
   PubMed Web of Science ®Google Scholar
• Montminy EM, Zhou M, Maniscalco L, et al. Contributions of adenocarcinoma and carcinoid tumors to early-onset colorectal cancer incidence rates in the United States. Ann Intern Med. 2021;174(2):157–166. doi:10.7326/M20-0068
   PubMed Web of Science ®Google Scholar
• Yang J, Du XL, Li ST, et al. Characteristics of differently located colorectal cancers support proximal and distal classification: a population-based study of 57,847 patients. PLoS One. 2016;11(12):e0167540. doi:10.1371/journal.pone.0167540
   PubMed Web of Science ®Google Scholar
• Gao XH, Yu GY, Gong HF, et al. Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer. Sci Rep. 2017;7(1):7882. doi:10.1038/s41598-017-08413-z
   PubMed Web of Science ®Google Scholar
• Petrelli F, Tomasello G, Borgonovo K, et al. Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA Oncol. 2017;3(2):211–219. doi:10.1001/jamaoncol.2016.4227
   PubMed Web of Science ®Google Scholar
• Zheng C, Jiang F, Lin H, et al. Clinical characteristics and prognosis of different primary tumor location in colorectal cancer: a population-based cohort study. Clin Transl Oncol. 2019;21(11):1524–1531. doi:10.1007/s12094-019-02083-1
   PubMed Web of Science ®Google Scholar
• Qiu MZ, Pan WT, Lin JZ, et al. Comparison of survival between right-sided and left-sided colon cancer in different situations. Cancer Med. 2018;7(4):1141–1150. doi:10.1002/cam4.1401
   PubMed Web of Science ®Google Scholar
• Weiss JM, Pfau PR, O’Connor ES, et al. Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results–Medicare data. J Clin Oncol. 2011;29(33):4401–4409. doi:10.1200/JCO.2011.36.4414
   PubMed Web of Science ®Google Scholar
• Xi Y, Yuefen P, Wei W, et al. Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer. J Transl Med. 2019;17(1):353. doi:10.1186/s12967-019-2102-1
   PubMed Web of Science ®Google Scholar
• Feng H, Lyu Z, Zheng J, et al. Association of tumor size with prognosis in colon cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Surgery. 2021;169(5):1116–1123. doi:10.1016/j.surg.2020.11.011
   PubMed Web of Science ®Google Scholar
• Liu J, Huang X, Yang W, et al. Nomogram for predicting overall survival in stage II-III colorectal cancer. Cancer Med. 2020;9(7):2363–2371. doi:10.1002/cam4.2896
   PubMed Web of Science ®Google Scholar
• Li Y, Liu W, Zhou Z, et al. Development and validation of prognostic nomograms for early-onset locally advanced colon cancer. Aging. 2020;13(1):477–492. doi:10.18632/aging.202157
   PubMedGoogle Scholar
• Li Y, Liu W, Zhao L, et al. Nomograms predicting overall survival and cancer-specific survival for synchronous colorectal liver-limited metastasis. J Cancer. 2020;11(21):6213–6225. doi:10.7150/jca.46155
   PubMed Web of Science ®Google Scholar
• Fu J, Wu L, Jiang M, et al. Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value. J Surg Oncol. 2016;114(8):1004–1008. doi:10.1002/jso.24437
   PubMed Web of Science ®Google Scholar
• Vallam KC, Desouza A, Bal M, Patil P, Engineer R, Saklani A. Adenocarcinoma of the rectum-A composite of three different subtypes with varying outcomes? Clin Colorectal Cancer. 2016;15(2):e47–e52. doi:10.1016/j.clcc.2015.12.004
   PubMed Web of Science ®Google Scholar
• Chand M, Rasheed S, Bhangu A, et al. Adjuvant chemotherapy improves overall survival after TME surgery in mucinous carcinoma of the rectum. Eur J Surg Oncol. 2014;40(2):240–245. doi:10.1016/j.ejso.2013.11.005
   PubMed Web of Science ®Google Scholar
• Hugen N, van de Velde CJ, Bosch SL, et al. Modern treatment of rectal cancer closes the gap between common adenocarcinoma and mucinous carcinoma. Ann Surg Oncol. 2015;22(8):2669–2676. doi:10.1245/s10434-014-4339-5
   PubMed Web of Science ®Google Scholar
• Mekenkamp LJ, Heesterbeek KJ, Koopman M, et al. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur J Cancer. 2012;48(4):501–509. doi:10.1016/j.ejca.2011.12.004
   PubMed Web of Science ®Google Scholar
• Quénet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, Phase 3 trial. Lancet Oncol. 2021;22(2):256–266. doi:10.1016/S1470-2045(20)30599-4
   PubMed Web of Science ®Google Scholar
• Gruber-Rouh T, Naguib NN, Eichler K, et al. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period. Int J Cancer. 2014;134(5):1225–1231. doi:10.1002/ijc.28443
   PubMed Web of Science ®Google Scholar
• Gao P, Huang XZ, Song YX, et al. Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study. BMC Cancer. 2018;18(1):234. doi:10.1186/s12885-018-4138-7
   PubMed Web of Science ®Google Scholar
• Hershman D, Hall MJ, Wang X, et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer. 2006;107(11):2581–2588. doi:10.1002/cncr.22316
   PubMed Web of Science ®Google Scholar
• Xu F, Rimm AA, Fu P, Krishnamurthi SS, Cooper GS. The impact of delayed chemotherapy on its completion and survival outcomes in stage II colon cancer patients. PLoS One. 2014;9(9):e107993. doi:10.1371/journal.pone.0107993
   PubMed Web of Science ®Google Scholar
• Healy MA, Morris AM, Abrahamse P, Ward KC, Kato I, Veenstra CM. The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer. 2018;18(1):481. doi:10.1186/s12885-018-4405-7
   PubMed Web of Science ®Google Scholar